Arcadia Biosciences (NASDAQ:RKDA) is scheduled to announce its earnings results after the market closes on Wednesday, August 8th. Analysts expect the company to announce earnings of ($1.29) per share for the quarter.

Arcadia Biosciences (NASDAQ:RKDA) last issued its quarterly earnings results on Wednesday, May 9th. The basic materials company reported ($4.86) earnings per share (EPS) for the quarter. The business had revenue of $0.21 million for the quarter. Arcadia Biosciences had a negative return on equity of 259.46% and a negative net margin of 686.10%. On average, analysts expect Arcadia Biosciences to post $-5 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Shares of Arcadia Biosciences opened at $6.37 on Tuesday, reports. The firm has a market cap of $16.38 million, a PE ratio of -0.93 and a beta of -5.77. Arcadia Biosciences has a 12-month low of $3.60 and a 12-month high of $66.56.

A number of equities analysts have recently issued reports on RKDA shares. HC Wainwright set a $20.00 price target on Arcadia Biosciences and gave the stock a “buy” rating in a research report on Thursday, July 19th. ValuEngine raised Arcadia Biosciences from a “sell” rating to a “hold” rating in a research report on Thursday, April 12th.

About Arcadia Biosciences

Arcadia Biosciences, Inc, an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits.

Further Reading: Market Capitalization – What it Means for Investors

Earnings History for Arcadia Biosciences (NASDAQ:RKDA)

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with's FREE daily email newsletter.